Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer

被引：0
|
作者：
Takashi Okuyama
Shinichi Sameshima
Emiko Takeshita
Takashi Mitsui
Takuji Noro
Yuko Ono
Tamaki Noie
Shinichi Ban
Masatoshi Oya
机构：
[1] Saitama Medical Center,Department of Surgery
[2] Dokkyo Medical University,Department of Pathology, Saitama Medical Center
[3] Dokkyo Medical University,undefined
来源：
BMC Cancer | / 20卷
关键词：
Myxoid stroma; Desmoplastic reaction; Stage II colon cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
    van den Broek, Evert
    Krijgsman, Oscar
    Sie, Daoud
    Tijssen, Marianne
    Mongera, Sandra
    van de Wiel, Mark A.
    Belt, Eric J. Th.
    den Uil, Sjoerd H.
    Bril, Herman
    Stockmann, Hein B. A. C.
    Ylstra, Bauke
    Carvalho, Beatriz
    Meijer, Gerrit A.
    Fijneman, Remond J. A.
    ONCOTARGET, 2016, 7 (45) : 73876 - 73887
  • [32] Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
    Zhang, Chunze
    Zhan, Yixiang
    Ni, Kemin
    Liu, Zhaoce
    Xin, Ran
    Han, Qiurong
    Li, Guoxun
    Ping, Hangyu
    Liu, Yaohong
    Zhao, Xuanzhu
    Wang, Wanting
    Yan, Suying
    Sun, Jing
    Zhang, Qinghuai
    Wang, Guihua
    Zhang, Zili
    Zhang, Xipeng
    Hu, Xia
    BMC CANCER, 2022, 22 (01)
  • [33] Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
    Chunze Zhang
    Yixiang Zhan
    Kemin Ni
    Zhaoce Liu
    Ran Xin
    Qiurong Han
    Guoxun Li
    Hangyu Ping
    Yaohong Liu
    Xuanzhu Zhao
    Wanting Wang
    Suying Yan
    Jing Sun
    Qinghuai Zhang
    Guihua Wang
    Zili Zhang
    Xipeng Zhang
    Xia Hu
    BMC Cancer, 22
  • [34] STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS.
    Mesker, W.
    Johnstone, E.
    Huijbers, A.
    van Pelt, G.
    Midgley, R.
    Morreau, H.
    Kerr, D.
    Tollenaar, R.
    ANNALS OF ONCOLOGY, 2010, 21 : 207 - 208
  • [35] STROMA PRODUCTION AND DOWNREGULATION OF SMAD4 CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS
    Mesker, W.
    Liefers, G.
    Morreau, H.
    Tanke, H.
    Tollenaar, R.
    ANNALS OF ONCOLOGY, 2009, 20 : 19 - 20
  • [36] Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer
    Liming Wang
    Yasumitsu Hirano
    Toshimasa Ishii
    Hiroka Kondo
    Kiyoka Hara
    Nao Obara
    Shigeki Yamaguchi
    World Journal of Surgical Oncology, 18
  • [37] Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer
    Wang, Liming
    Hirano, Yasumitsu
    Ishii, Toshimasa
    Kondo, Hiroka
    Hara, Kiyoka
    Obara, Nao
    Yamaguchi, Shigeki
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [38] Modern Era Adjuvant Chemotherapy is associated with Improved Survival in Patients with Stage II Colon Cancer
    Casadaban, L.
    Aklilu, M.
    Villenes, D.
    Raucher, G.
    Freels, S.
    Maker, A. V.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S10 - S11
  • [39] The Clinical effects and prognosis of postoperative FOLFOX4 chemotherapy on patients with stage II/III colon cancer
    Qi, Hongming
    Tang, Xuhua
    Zhang, Hui
    Zhou, Hongzhi
    Lou, Shanye
    Zhu, Tieming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 4581 - 4586
  • [40] How I treat stage II colon cancer patients
    Taieb, J.
    Karoui, M.
    Basile, D.
    ESMO OPEN, 2021, 6 (04)
12345